Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.
about
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesisThe mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trialsChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsObesity-Related Digestive Diseases and Their PathophysiologyMolecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPKInflammation- and stress-related signaling pathways in hepatocarcinogenesisA liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesThe potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinomaAdiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in miceDietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.Obesity, adipokines and hepatocellular carcinoma.Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.Adiponectin ameliorates experimental periodontitis in diet-induced obesity mice.Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice.Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling.The role of adiponectin in cancer: a review of current evidence.Obesity and cancer--mechanisms underlying tumour progression and recurrenceNon alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.Adiponectin is a potential catabolic mediator in osteoarthritis cartilageMultiple signal pathways in obesity-associated cancer.ω3-PUFAs exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients.Rapamycin and mTORC1 inhibition in the mouse: skin cancer prevention.LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma.Association analysis of genetic variants of adiponectin gene and risk of pancreatic cancerElevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control StudyMetabolic syndrome, obesity, and gastrointestinal cancerSignificance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis.Role of adiponectin and its receptors in cancerEvolving role of adiponectin in cancer-controversies and update.A clinical perspective of the link between metabolic syndrome and hepatocellular carcinomaInsulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma.Obesity, inflammation, and liver cancer.Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis.Mouse models for liver cancer.Obesity, adipokines and cancer: an update.Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes.
P2860
Q24614006-424EC1AA-528C-45B2-81EC-B4A8FB6D88BDQ26751155-DF4CE89D-DB5E-4B97-A1F5-32B7726F5ABEQ26772302-4DF98E4B-81D3-4BDA-8D54-53E09A04A599Q28073381-8B600059-10A3-4608-8F2A-0FDE9740B44FQ28384866-12BDF807-3D2A-4D60-BB96-80AF89BB773EQ28387669-6548FC0B-7E33-4DCB-ABD0-8072BD907A5BQ28392033-25E0845A-28F8-4C15-A066-1FDE580663E6Q28392224-A7FC2C2A-057C-4716-BA60-9B82110741D6Q28543721-42D90848-A96F-498B-8847-77ECB6B9B1BBQ30301218-A5730CE9-521A-4CC8-B725-8EC48BDC23DAQ30427127-CFE089FF-E722-4564-AA8D-8FB5D06B45BBQ33563809-8EAF13D9-FCB5-4FBD-BCA3-24973845EB18Q33623578-AC5CA1A3-D091-4E05-9A51-71ABF75BF180Q33660027-8392562C-4E4F-4FC7-91F5-F550FAAD05EDQ33944911-77FE1D29-20C1-492F-8F59-D403344558F5Q34081435-437427EF-6A4B-4BFF-A828-B46476B8C266Q34104012-1C818577-1E82-49F0-A6EB-962B2F1460F8Q34271986-9FB46F69-1A7F-47C9-9BA8-16514F95637AQ34425077-5C2AEDBD-7734-45E5-BB03-77543F9BE339Q34589677-DAB8BE10-67C0-4FFB-842A-B0EC3B0A08A6Q34614117-DE0D6FAE-3C06-4970-BAF3-24448215D010Q34633750-FDE2A202-01C5-4E75-839A-713621B66999Q35015164-9801270B-F5ED-42D6-9C36-322493B66A98Q35106935-DF1B208B-2660-4A09-BDD3-9CD00E75D71BQ35812050-51F74819-BADC-4AAF-955B-4A01451986CEQ35871056-E913A5CB-963E-4CB4-A399-BA6E1BAD17CEQ36230381-013652E1-0934-423D-8E6E-8D5BCFC246C4Q36488807-2F96CD1E-F25B-4FBC-86E6-611B4453C989Q36812856-D6A3B00C-457F-4E2E-B1E6-1EE42C23A580Q36814438-074CFC5B-F481-4D76-B7B5-1E425CFF03BCQ36849638-7892E76A-0FEF-45FC-80B9-78EBC7172147Q37031745-156E7160-AA04-4410-BC3F-417DCB7C41ADQ37417134-6A7081D6-4781-4D3A-8C6F-AA2049B2B936Q37469981-8F9C909D-E2CE-49C5-BB15-A65382142FB7Q37678957-D66CF5B8-1B3B-46F6-A642-98D9F0D6BE28Q38040323-7D41B242-7609-4194-BA7F-C7E566680F50Q38083387-1B1253E6-299F-4FC6-BA41-0BE4DCB5B5A7Q38267868-C4DAF650-27FD-42AE-94E8-A7EA60744FDAQ38552383-B88B0A33-6D95-40B7-A617-363B80D2CDBCQ38594016-17CDE305-1637-4F27-B39C-8056DA150B21
P2860
Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@ast
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@en
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@nl
type
label
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@ast
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@en
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@nl
prefLabel
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@ast
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@en
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Adiponectin modulates C-jun N- ...... bits hepatocellular carcinoma.
@en
P2093
Arumugam Nagalingam
Cynthia Cohen
Dipali Sharma
Frank A Anania
Jason Wang
Jeffrey Handy
Mourad Tighiouart
Neeraj K Saxena
P2860
P304
1762-73, 1773.e1-5
P356
10.1053/J.GASTRO.2010.07.001
P407
P577
2010-07-13T00:00:00Z